CA-ESRI
27.1.2021 17:02:08 CET | Business Wire | Press release
Esri , the global leader in location intelligence, today announced the launch of ArcGIS Platform, a geospatial platform as a service (PaaS) for developers that need to integrate location capabilities into their apps, business systems, and products. ArcGIS Platform gives developers direct access to Esri's powerful location services using the APIs and web frameworks of their choice.
"ArcGIS Platform lets users build their own products or integrate Esri services into existing software," said Jack Dangermond, Esri founder and president. "This PaaS makes it easier for software developers to access geospatial technology."
"With the release of ArcGIS Platform, developers now have access to professional-grade content and capabilities they can readily plug into their apps, allowing them to stay on budget while delivering enormous value by reducing time to market," said David Cardella, Esri product manager for developer technologies.
Scaling with developers and their apps, ArcGIS Platform lets customers leverage the same framework and services whether they're supporting dozens of users or millions of them.
"We're excited our partnership with Esri has continued with the integration of ArcGIS Platform," said Ben Brantly, VP of product at Salesforce. "Esri's collection of ready-to-use basemaps gives our users a solution to better understand their data by presenting it visually on a map. The capabilities of ArcGIS Platform allow us to continue to expand the value we provide to Salesforce Maps users by leveraging additional Esri location services as well as the adoption of the ArcGIS API for JavaScript."
Esri is unveiling ArcGIS Platform at a virtual event today, where users like Salesforce and cloud-based drone management capability provider Airspace Link are speaking about how they use Esri's PaaS technology.
"Fused with local data, Esri's demographic and geocoding services help us deliver a product that promotes safe, compliant drone operations for our customers across the country," said Airspace Link Cofounder, President, and CEO Michael Healander.
Longtime Esri partner, SAP, is also featured in the launch event. “Location services from Esri’s ArcGIS Platform will be exposed through SAP’s cloud consumption model, which plays to the strength of what customers are looking for,” said Irfan Khan, President for Platform &Technology at SAP. “SAP’s Business Technology Platform provides an ideal integration point, allowing developers to more easily build innovative applications that combine real-time business data with geospatial intelligence.”
To learn more about Esri, a leader in The Forrester Wave™: Location Intelligence Platforms, Q2 2020, and ArcGIS Platform and how it delivers low-cost, high-quality location services to developers, visit go.esri.com/Platform-Learn-More .
About Esri
Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in more than 350,000 organizations globally and in over 200,000 institutions in the Americas, Asia and the Pacific, Europe, Africa, and the Middle East, including Fortune 500 companies, government agencies, nonprofits, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial information technology, Esri engineers the most innovative solutions for digital transformation, the Internet of Things (IoT), and advanced analytics. Visit us at esri.com .
Copyright © 2021 Esri. All rights reserved. Esri, the Esri globe logo, ArcGIS, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.
Additional Quotes
“Esri’s location services integrate easily with Autodesk – together we’re changing the way the industry works.”
Theo Angelopoulos, Senior Director, Infrastructure Business Strategy & marketing, Autodesk
“With the launch of Esri’s new location platform, we look forward to accessing a greater number of services with more flexibility to make our offerings even more meaningful.”
George Mastakas, VP Enterprise Solutions and Corporate Partnerships, CityWorks
“Reliable, scalable location services from Esri allow us to focus on delivering innovative solutions.”
Brian J. Smith, Senior Vice President, GeoDecisions – A Division of Gannett-Fleming, Inc.
“The flexibility, increased speed, and variety of mapping and imagery layers gives our users unprecedented control over their risk assessments.”
John Goolgasian, Chief Operating Officer, Geospark Analytics
“We rely on Esri location services to provide scalable, tailored solutions for our customers.”
Steve Mulberry, Geospatial Innovation Strategist, GISinc
“With the seemingly endless capabilities provided by Esri location services, K&A can quickly and effectively integrate location intelligence into our solutions and our clients’ business workflows for an improved customer experience.”
Walid Abou Chacra, Manager, Electricity Segment, Khatib & Alami
“We highly recommend Esri location services as the premier technology to help utilities optimize their network for the future.”
Chris Erpelding, GIS Consulting Department Manager, POWER Engineers
“Esri location services enables Schneider Electric to build world class solutions that manage the lifecycle of the Utility Network.”
Jay Stinson, Vice President, Digital Grid Asset Management Business, Schneider Electric
“The newest ArcGIS Platform architecture enables us to provide solutions embedding advanced spatial capabilities to our customers faster and easier than ever before.”
Signe Bramming Andersen, Director of Business Development, Similix
“Esri location services provide flexibility in our programs and products, and expands the value of GIS for our customers.”
Adam Tonkin, CTO, SSP Innovations
“Esri’s location services are a crucial component of Cartegraph’s mission to optimize the productive life of every infrastructure asset – indoors, outdoors, above and below ground.”
Josh Mallamud, CEO, Cartegraph
“When our customers need to provision high-precision apps for offline field work with Geocortex Mobile, or publish modern mapping apps with all the tools tailored for their staff’s needs, they rely on Geocortex and ArcGIS Platform to take those apps to the next level.”
Jon Brooks, CEO, VertiGIS
View source version on businesswire.com: https://www.businesswire.com/news/home/20210127005050/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom